Foresight Technology VCT PLC
17 January 2007
Conversion and redesignation of shares
Board composition
The Board of Foresight VCT plc announces that following approval at the EGM the
Ordinary Shares fund and C Shares fund have now merged.
The respective net asset values were calculated on 15 January 2007 at 56.03p per
Ordinary Share and 81.43p per C Share, and the conversion ratio has therefore
been calculated as 0.6880756. Ordinary Shareholders will therefore receive
0.6880756 C Shares for each Ordinary Share held at the close of business on 15
January 2007. Accordingly 14,791,348 Ordinary Shares were converted into
10,177,029 C Shares. Following this conversion there were in aggregate
45,153,120 C Shares in issue, which have now been redesignated as 45,153,120 new
Ordinary Shares.
In addition, as explained in the EGM Circular, Roger Blears, Peter English and
David Royds have now resigned from the Board of the Company.
For further information please contact:
Gary Fraser, Foresight Venture Partners: 01732 471800
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.